243 related articles for article (PubMed ID: 15243470)
1. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W
Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
[TBL] [Abstract][Full Text] [Related]
3. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
4. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer.
Rieger JM; Jha N; Lam Tang JA; Harris J; Seikaly H
Head Neck; 2012 Feb; 34(2):168-74. PubMed ID: 21416547
[TBL] [Abstract][Full Text] [Related]
5. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
6. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
7. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia.
Haddad P; Karimi M
Radiother Oncol; 2002 Jul; 64(1):29-32. PubMed ID: 12208571
[TBL] [Abstract][Full Text] [Related]
9. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced hyposalivation and its treatment with oral pilocarpine.
Niedermeier W; Matthaeus C; Meyer C; Staar S; Müller RP; Schulze HJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):541-9. PubMed ID: 9830645
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC
J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499
[TBL] [Abstract][Full Text] [Related]
12. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
Warde P; O'Sullivan B; Aslanidis J; Kroll B; Lockwood G; Waldron J; Payne D; Bayley A; Ringash J; Kim J; Liu FF; Maxymiw W; Sprague S; Cummings BJ
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):9-13. PubMed ID: 12182969
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
[TBL] [Abstract][Full Text] [Related]
14. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Nusair S; Rubinow A
Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
[TBL] [Abstract][Full Text] [Related]
15. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
16. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
[TBL] [Abstract][Full Text] [Related]
17. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
18. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
19. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
Mateos JJ; Setoain X; Ferre J; Rovirosa A; Navalpotro B; Martin F; Ortega M; Lomeña F; Fuster D; Pavia J; Pons F
Nucl Med Commun; 2001 Jun; 22(6):651-6. PubMed ID: 11403176
[TBL] [Abstract][Full Text] [Related]
20. Prevention of oral and salivary gland impairment in irradiated adolescent patients with head and neck cancer: a suggested protocol.
Davidovich E; Peretz B; Aframian DJ
Quintessence Int; 2007 Mar; 38(3):235-9. PubMed ID: 17334001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]